Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy…
By E. Shaw, R. Arusell, B. Scheithauer, J. O'fallon, B. O’Neill, R. Dinapoli, D. Nelson, J. Earle, C. Jones, T. Cascino and 5 more. Journal of Clinical Oncology, 2002
667 citations recorded by the source corpus.
Subfields: Epidemiology, Genetics, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/68addcf33be3a413a54c590d242e14b605a0ef04
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- GLIOMA EXTENT OF RESECTION AND ITS IMPACT ON PATIENT OUTCOME (2008, methodology): “In the seven remaining series, oligodendrogliomas and oligoastrocytomas composed 20 (51), 25 (16), 51 (56), 57 (46), 63 (25), 68 (41), and 78% (5) of the study populations.”
- A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. (2006, methodology): “(12), and 93-72-02, a phase II trial of six cycles of procarbazine, lomustine, and vincristine (PCV) chemotherapy followed by 54.”
- Radiation-induced brain injury: A review (2012, background): “Shaw et al published results of a randomized trial in 200 adult low-grade glioma patients who received either 50.4 Gy or 64.8 Gy at 1.8 Gy per fraction to partial brain treatment fields (Shaw et al, 2002).”
- High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014, background): “8 Gy) of irradiation; the lower dose was equivalent to the higher dose with less toxicity [44, 45].”